维普中文期刊产品整合服务
37篇 您的检索式:作者名="Langer SW"
    题名 作者 年代 出处 被引量
1Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3):The NORDIc NEC study显示文摘Sorbye H Welin S Langer SW 2013Ann Oncol2013,24,1:1
2Treatment of anthracyclin ex- travasation with savene (dexrazoxane): results from two prospective clinical nmlti- centre studies显示文摘Mouridsen HT Langer SW Buter J 2007Ann Oncol2007,18,3:1
3Treatment of experi- mental extravasation of amrubicin, liposomal doxorubicin,and mitox- antrone with dexrazoxane显示文摘Langer SW Thougaard AV Sehested M 2012Cancer Chemother Pharmacol2012,69,:1
4Treatment of anthracyeline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone 显示文摘Langer SW 2006Cancer Chemother Pharmacol2006,57,1:1
5Treatment of anthracycline extravasation with saven edexrazoxane results from two prospective clinical multicentre studies 显示文摘Mouridsen HT Langer SW Buter J 2007Ann Oncol2007,18,3:1
6Phase II study of iressa(gefitinib)in relapsed and refractory small cell lung cancer(SCLC)显示文摘Langer SW Pedersen BS Ranson M 2008J Thor Oncol2008,3,55:1
7Dexrazoxane is a potent and specific inhibitor of anthracycline induced subcutaneous lesion in mice显示文摘Langer SW Sehested M Jensen PB 2001Ann Oncol2001,12,3:1
8Dexrazoxane is a potent and specific inhibitor of anthracyline induced subcutaneous lesions in mice显示文摘Langer SW Sehested M Jensen PB 2001Ann Oncol2001,12,3:1
9Treatmentof anthracycline extravasation with dexrazoxane显示文摘Langer SW Sehested M Jensen PB 2000Clin Cancer Res2000,6,9:1
10Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone显示文摘Langer SW Thougaard AV Sehested M 2006Cancer Chemother Pharmacol2006,57,1:1
11Treatment of anthracyclin extravasation with savene(dexrazoxane):results from two prospective clinical multicentre studies显示文摘Mouridsen HT Langer SW Buter J 2007Ann Oncol2007,18,3:1
12Treatment of anthracycline extravasation with Savene(dexrazoxane):results from two prospective clinical multicentre studies显示文摘Mouridsen HT Langer SW Buter J 2007Ann Oncol2007,18,3:1
13Neuroendocrine carcinomas of the gastroenteropan-ereatic system: a comprehensive review 显示文摘Ilett EE Langer SW Olsen IH 2015Diagnostics (Basel)2015,5,2:1
14Treatment of anthraeycline extrava- sation with dexrazoxane显示文摘Langer SW Sehested M Jensen PB 2000Clin Cancer Res2000,6,9:1
15Other uses of dexrazoxane:savene,the first proven antidote against anthracycline extravasation injuries显示文摘Langer SW Jensen PB Sehested M 2007Cardiovasc Toxicol2007,7,2:1
16Treatment of anthracycline extravasation with Savene (dexrazoxane):results from two prospective clinical multicentre studies显示文摘Mouridsen HT Langer SW Buter J 2007Ann Oncol2007,18,3:1
17Dexrazoxane for the treatment of chemotherapy- related side effects显示文摘Langer SW 2014Cancer Manag Res2014,6,:1
18A prospective studyof PET/CT in initial staging of small-cell lung cancer: compari?son with CT, bone scintigraphy and bone marrow analysis 显示文摘Fischer BM Mortensen J Langer SW 2007Ann Oncol2007,18,2:1
19Dexrazoxane for the treatment of chemotherapy-related side effects显示文摘Langer SW 2014Cancer Manag Res2014,6,:1
20Anthracyeline extravasation:a comprehensive review of experimental and clinical treatments显示文摘Langer SW Sehested M Jensen PB 2009Tumori2009,95,3:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费